Looking on the internet deeply has found these results:

There is no difference in the test. is the most popular phrase on the web.

There is no difference in the testing. 12 results on the web	There is no difference in the test. 16,490,000 results on the web More popular!
Some examples and use cases from the internet:	Some examples and use cases from the internet:
There is no difference in exposure of lumiracoxib in men and women. There is no difference in approach. There is no difference in dosage between symptomatic and presymptomatic patients. Moreover, there is no difference in use between those products. Concerning the Member States where it has been contested, you are quite right, because there are differences in testing procedures. There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont. There is no difference in blood. There is no difference in exposure among Chinese, Japanese, and Korean subjects.	There is no difference in dosage between symptomatic and presymptomatic patients. There is no difference in approach. There is no difference in blood. But there is no difference among the Member States as to where we stand in relation to the nuclear tests. There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont. Moreover, there is no difference in use between those products. There is no difference in exposure among Chinese, Japanese, and Korean subjects. There is no difference in exposure of lumiracoxib in men and women.

There is no difference in the testing.

12 results on the web

There is no difference in the test.

16,490,000 results on the web

More popular!

There is no difference in exposure of lumiracoxib in men and women.
There is no difference in approach.
There is no difference in dosage between symptomatic and presymptomatic patients.
Moreover, there is no difference in use between those products.
Concerning the Member States where it has been contested, you are quite right, because there are differences in testing procedures.
There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont.
There is no difference in blood.
There is no difference in exposure among Chinese, Japanese, and Korean subjects.

There is no difference in dosage between symptomatic and presymptomatic patients.
There is no difference in approach.
There is no difference in blood.
But there is no difference among the Member States as to where we stand in relation to the nuclear tests.
There is no difference in the oral bioavailability of nicotinic acid in men and women receiving Pelzont.
Moreover, there is no difference in use between those products.
There is no difference in exposure among Chinese, Japanese, and Korean subjects.
There is no difference in exposure of lumiracoxib in men and women.